Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening of the entire coding region of p53 in low grade lymphoproliferative disorders.

Molecular pathology : MP - 1 Aug 2000

Bromidge T J, Howe D J

Abstract excerpt

This report details a rapid method for screening the entire p53 coding region (exons 2-11). This method, based on the non-isotopic RNase cleavage assay, uses novel primer sequences and an adaptation of the MutationScreener method. A mutation in 20% of the sample was easily detectable by this method, whereas mutations below 50% were undetectable using the original method. Alterations to the wild-type p53 mRNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, p53
Share to Lymphoproliferative Disorders
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Ribonucleases

Share to RNA, Messenger

Share to RNA, Neoplasm

Share to Sensitivity and Specificity

Source

Open in PubMed Open full text

Identifiers

PMID: 11040946
DOI: 10.1136/mp.53.4.216
PMCID: PMC1186973

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening of the entire coding region of p53 in low grade lymphoproliferative disorders.PMID 11040946Read ↗

Mutations spanning P53 exons 5-9 detected by non-isotopic RNAse cleavage assay and protein expression in human colon cancer.Semantic proximity Read ↗

DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies.Semantic proximity Read ↗

Detection of mutations in human cancer using nonisotopic RNase cleavage assay.Semantic proximity Read ↗

A rapid and nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors.Semantic proximity Read ↗

RNase cleavage-based methods for mutation/SNP detection, past and present.Semantic proximity Read ↗

Detection of single nucleotide polymorphisms using a non-isotopic RNase cleavage assay.Semantic proximity Read ↗

High incidence of mutations of the p53 gene detected in ovarian tumours by the use of chemical mismatch cleavage.Semantic proximity Read ↗

Surveyor nuclease-based detection of p53 gene mutations in haematological malignancy.Semantic proximity Read ↗

Detection of p53 gene mutation by rapid PCR-SSCP and its association with poor survival in breast cancer.Semantic proximity Read ↗

Sensitive detection of p53 gene mutations by a 'mutant enriched' PCR-SSCP technique.Semantic proximity Read ↗

Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array.Semantic proximity Read ↗

APEX disease gene resequencing: mutations in exon 7 of the p53 tumor suppressor gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.